EU Approves Higher Dose of Wegovy for Weight Loss

Mar 2, 2026

67 min

Mar 2, 2026 00:30

Higher maintenance dose of weight-loss drug Wegovy approved in EU. When will UAE get it?

## EU Approval of Wegovy's Higher Dose

The European Commission has approved a 7.2 mg weekly dose of the weight-loss drug Wegovy, following a positive review by the European Medicines Agency. This decision allows for a stronger treatment option for obesity patients in the EU who need further weight reduction after using lower doses.

## Implications for the UAE

While the EU has given the green light, the timeline for Wegovy's availability in the UAE remains unclear. Novo Nordisk, the drug's manufacturer, is in discussions with UAE regulators but has not provided a specific timeline for approval.

## Clinical Trial Results

The approval was based on trials involving nearly 2,000 participants, showing significant weight loss. Participants on the higher dose lost about 20% of their body weight on average, with one-third achieving over 25% weight loss. Most of the weight loss was from fat, not muscle, which is important for metabolic health. Reported side effects included nausea and diarrhea, generally mild and temporary.

## Global Demand and Future Prospects

The demand for medical weight-loss treatments is rising globally due to increasing obesity rates and related health risks. The new dosage offers more flexibility for healthcare providers to tailor treatments. However, the availability of this higher dose in the UAE will depend on the completion of local regulatory reviews, which may take several months.

Read the full story at the source

What you need to know to get Emirates ID?

Leave your details and get a guide as a gift to avoid mistakes

Article contents